Target intelligence / Profile preview

N-acetylglutamate kinase (NAGK)

Target
NAGK
Molecular classification
Enzyme, Amino acid kinase, Acetylglutamate kinase family, Transferase (specifically, phosphotransferase with a carboxy group as acceptor)
01

Overview

N-acetylglutamate kinase (NAGK) is an enzyme that catalyzes the phosphorylation of N-acetylglutamate (NAG) using ATP, producing N-acetylglutamyl phosphate. This reaction is the second step in the arginine biosynthesis pathway in microorganisms and plants. The enzyme's activity is regulated by feedback inhibition by arginine; when arginine levels are high, NAGK is inhibited to reduce arginine synthesis[6][3][4]. Structurally, NAGK forms ring-like oligomeric assemblies (often hexamers or tetramers) with distinct N- and C-terminal domains where the active sites for NAG and ATP are located[4]. There are no direct human diseases associated with NAGK deficiency, as animals do not possess this enzyme in their urea cycle; the human urea cycle uses N-acetylglutamate synthase (NAGS) instead[5]. However, in bacteria and plants, NAGK is essential for de novo arginine production[6][3]. If you need further details or structured information, specialized databases such as UniProt or BRENDA will provide in-depth molecular and regulatory annotations on N-acetylglutamate kinase.

Other names
NAG kinaseNAGKAcetylglutamate kinaseEC 2.7.2.8
02

Biological functions

Arginine biosynthesis (phosphorylates N-acetylglutamate to N-acetylglutamyl phosphate, a precursor of ornithine and subsequently arginine)Regulation by allosteric effectors (arginine acts as an inhibitor in many bacteria and plants)
03

Disease associations

Other (No direct human diseases known; in microorganisms, disruption affects arginine synthesis, which can impact pathogenesis and growth)

Beyond the preview

Go deeper on N-acetylglutamate kinase (NAGK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-acetylglutamate kinase (NAGK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call